I’m 65, tired of working and have very little savings — is it possible to live off CPP alone? Yes, but you'll need to make these 3 big sacrifices Brothers who escaped flooded Texas camp speak ...

About the Setrusumab Phase 3 Program Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 ...

The Cosmic study has enrolled 69 patients at 21 sites across 7 countries. About Osteogenesis Imperfecta (OI) Osteogenesis Imperfecta (OI) includes a group of genetic disorders impacting bone ...

The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI); and alvelestat for the treatment of severe alpha-1 antitrypsin deficiency ...

Ultragenyx, Mereo BioPharma announce UX143 phase 3 Orbit study for osteogenesis imperfecta progressing to final analysis ...

NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled ...

O-i Glass is listed on the CBOE trading with ticker code OI.US. It has a market capitalisation of $2.23b, with approximately 154.68m shares in issue. Over the last year, O-i Glass share price has ...

Oil Price: Get all information on the Price of Oil including News, Charts and Realtime Quotes.

The table below is a calendar list view of unusual options activity which shows contracts which are trading at abnormal volume levels or price levels. Traders typically use unusual options ...

Light rain was falling in Washington by 6:30 p.m., with a light breeze cutting through some of the humidity of the day. Some spectators held up umbrellas. There was no sign of lightning, which ...